Exatecan Mesylate
≥99%
- Product Code: 100502
Alias:
Related CAS number 171335-80-1
CAS:
169869-90-3
| Molecular Weight: | 531.55 g./mol | Molecular Formula: | C₂₅H₂₆FN₃O₇S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Exatecan mesylate is primarily used in the field of oncology as a potent chemotherapeutic agent. It is a topoisomerase I inhibitor, which works by interfering with the DNA replication process in cancer cells, leading to their death. This compound is particularly effective in the treatment of various solid tumors, including colorectal, gastric, and pancreatic cancers. It is often utilized in combination with other chemotherapy drugs to enhance its efficacy and reduce the likelihood of drug resistance. Additionally, exatecan mesylate is being investigated in clinical trials for its potential use in treating other types of cancers, offering hope for improved therapeutic outcomes in patients with limited treatment options. Its ability to target and inhibit topoisomerase I makes it a valuable tool in the ongoing battle against cancer.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Light Yellow Solid |
| Purity (%) | 99-100 |
| Identificat(HNMR) | Consistent With Structure |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿8,600.00 |
+
-
|
| 0.005 | 10-20 days | ฿12,000.00 |
+
-
|
| 0.025 | 10-20 days | ฿18,760.00 |
+
-
|
| 0.100 | 10-20 days | ฿38,740.00 |
+
-
|
Exatecan Mesylate
Exatecan mesylate is primarily used in the field of oncology as a potent chemotherapeutic agent. It is a topoisomerase I inhibitor, which works by interfering with the DNA replication process in cancer cells, leading to their death. This compound is particularly effective in the treatment of various solid tumors, including colorectal, gastric, and pancreatic cancers. It is often utilized in combination with other chemotherapy drugs to enhance its efficacy and reduce the likelihood of drug resistance. Additionally, exatecan mesylate is being investigated in clinical trials for its potential use in treating other types of cancers, offering hope for improved therapeutic outcomes in patients with limited treatment options. Its ability to target and inhibit topoisomerase I makes it a valuable tool in the ongoing battle against cancer.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :